COL6A3 and neoplasm: The tumor is driven by a chromosomal translocation, t(1;2)(CSF-1;COL6A3), in the majority of cases, which is present in 2–16% of tumor cells, leading to the overexpression of CSF1 and recruitment of CSF1R macrophages, giant cells, and osteoclasts.